84 related articles for article (PubMed ID: 23553770)
1. The inhibition of p85αPI3KSer83 phosphorylation prevents cell proliferation and invasion in prostate cancer cells.
Feola A; Cimini A; Migliucci F; Iorio R; Zuchegna C; Rothenberger R; Cito L; Porcellini A; Unteregger G; Tombolini V; Giordano A; Di Domenico M
J Cell Biochem; 2013 Sep; 114(9):2114-9. PubMed ID: 23553770
[TBL] [Abstract][Full Text] [Related]
2. The p85α regulatory subunit of PI3K mediates cAMP-PKA and retinoic acid biological effects on MCF7 cell growth and migration.
Donini CF; Di Zazzo E; Zuchegna C; Di Domenico M; D'Inzeo S; Nicolussi A; Avvedimento EV; Coppa A; Porcellini A
Int J Oncol; 2012 May; 40(5):1627-35. PubMed ID: 22366926
[TBL] [Abstract][Full Text] [Related]
3. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
[TBL] [Abstract][Full Text] [Related]
4. Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase in a Hodgkin's lymphoma-derived cell line (CO).
Jücker M; Südel K; Horn S; Sickel M; Wegner W; Fiedler W; Feldman RA
Leukemia; 2002 May; 16(5):894-901. PubMed ID: 11986952
[TBL] [Abstract][Full Text] [Related]
5. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
[TBL] [Abstract][Full Text] [Related]
6. p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors.
Fransson S; Uv A; Eriksson H; Andersson MK; Wettergren Y; Bergo M; Ejeskär K
Oncogene; 2012 Jul; 31(27):3277-86. PubMed ID: 22020336
[TBL] [Abstract][Full Text] [Related]
7. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
[TBL] [Abstract][Full Text] [Related]
8. p85 regulatory subunit of PI3K mediates cAMP-PKA and estrogens biological effects on growth and survival.
Cosentino C; Di Domenico M; Porcellini A; Cuozzo C; De Gregorio G; Santillo MR; Agnese S; Di Stasio R; Feliciello A; Migliaccio A; Avvedimento EV
Oncogene; 2007 Mar; 26(14):2095-103. PubMed ID: 17016431
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit.
Shekar SC; Wu H; Fu Z; Yip SC; Nagajyothi ; Cahill SM; Girvin ME; Backer JM
J Biol Chem; 2005 Jul; 280(30):27850-5. PubMed ID: 15932879
[TBL] [Abstract][Full Text] [Related]
10. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells.
Zeng ZZ; Jia Y; Hahn NJ; Markwart SM; Rockwood KF; Livant DL
Cancer Res; 2006 Aug; 66(16):8091-9. PubMed ID: 16912186
[TBL] [Abstract][Full Text] [Related]
11. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer.
Luo J; Cantley LC
Cell Cycle; 2005 Oct; 4(10):1309-12. PubMed ID: 16131837
[TBL] [Abstract][Full Text] [Related]
12. Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits?
Geering B; Cutillas PR; Vanhaesebroeck B
Biochem Soc Trans; 2007 Apr; 35(Pt 2):199-203. PubMed ID: 17371237
[TBL] [Abstract][Full Text] [Related]
13. Roles of G beta gamma in membrane recruitment and activation of p110 gamma/p101 phosphoinositide 3-kinase gamma.
Brock C; Schaefer M; Reusch HP; Czupalla C; Michalke M; Spicher K; Schultz G; Nürnberg B
J Cell Biol; 2003 Jan; 160(1):89-99. PubMed ID: 12507995
[TBL] [Abstract][Full Text] [Related]
14. The structure of the inter-SH2 domain of class IA phosphoinositide 3-kinase determined by site-directed spin labeling EPR and homology modeling.
Fu Z; Aronoff-Spencer E; Backer JM; Gerfen GJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3275-80. PubMed ID: 12629217
[TBL] [Abstract][Full Text] [Related]
15. The regulatory mechanism of phosphatidylinositol 3-kinase by insulin in 3T3 L1 fibroblasts: phosphorylation-independent activation of phosphatidylinositol 3-kinase.
Kang I; Choi SL; Kim SS; Kim SJ; Ha J; Oh SM; Kim SS
Exp Mol Med; 1998 Dec; 30(4):263-9. PubMed ID: 9894159
[TBL] [Abstract][Full Text] [Related]
16. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
18. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
19. PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.
Zhu Z; He X; Johnson C; Stoops J; Eaker AE; Stoffer DS; Bell A; Zarnegar R; DeFrances MC
Biochem Biophys Res Commun; 2007 Jun; 358(1):66-72. PubMed ID: 17475214
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis signaling by the novel compound 3-Cl-AHPC involves increased EGFR proteolysis and accompanying decreased phosphatidylinositol 3-kinase and AKT kinase activities.
Farhana L; Dawson MI; Huang Y; Zhang Y; Rishi AK; Reddy KB; Freeman RS; Fontana JA
Oncogene; 2004 Mar; 23(10):1874-84. PubMed ID: 14981538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
